Study period | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Enrolment | Allocation | Post-allocation | Close-out | ||||||||
Timepoint** | -t1 | 0 | t1 | t2 | t3 | t4 | t5 | t6 | t7 | t8 | t9 |
Enrolment: | |||||||||||
Eligibility screen | X | ||||||||||
Informed consent | X | ||||||||||
Allocation | X | ||||||||||
Interventions: | |||||||||||
ESPB | X | ||||||||||
Control | X | ||||||||||
Assessments: | |||||||||||
Baseline characteristics | X | X | |||||||||
NRS for pain | X | X | X | X | X | ||||||
Hydromorphone consumption | X | X | |||||||||
QoR-15 | X | X | |||||||||
Fentanyl requirements | X | ||||||||||
Rescue analgesics | |||||||||||
Adverse events | |||||||||||
Mortality | X |